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ABSTRACT
Background/aims: To demonstrate how spectral
domain optical coherence tomography (SDOCT) can
better evaluate drusen and associated anatomical
changes in eyes with non-neovascular age-related
macular degeneration (AMD) compared with time domain
optical coherence tomography (TDOCT).
Methods: Images were obtained from three eyes of
three patients with AMD using an experimental SDOCT
system. Both a titanium–sapphire (Ti:sapphire) laser and a
superluminescent diode (SLD) were used as a broadband
light source to achieve cross-sectional images of the
retina. A qualitative and quantitative analysis was
performed for structural changes associated with non-
neovascular AMD. An automated algorithm was devel-
oped to analyse drusen area and volume from SDOCT
images. TDOCT was performed using the fast macular
scan (StratusOCT, Carl Zeiss Meditec, Dublin, California).
Results: SDOCT images can demonstrate structural
changes associated with non-neovascular AMD. A new
SDOCT algorithm can determine drusen area, drusen
volume and proportion of drusen.
Conclusions: With new algorithms to determine drusen
area and volume and its unprecedented simultaneous
ultra-high speed ultra-high resolution imaging, SDOCT can
improve the evaluation of structural abnormalities in non-
neovascular AMD.
Since Huang et al described the technology of
optical coherence tomography (OCT) over
15 years ago,1 OCT has become a widely used
technology in ophthalmology. The leading com-
mercially available instrument, the StratusOCT
(Carl Zeiss Meditec, Dublin, California), is based
on time domain OCT (TDOCT) technology. With
the StratusOCT, two-dimensional cross-sectional
retinal images consisting of 512 A-lines with axial
resolutions of 10 mm can be obtained in 1.28 s. In
order to improve resolution, ultra-high resolution
(UHR) OCT imaging, which also utilises time
domain technology, was developed and could
achieve axial resolutions of about 3 mm.2 3 UHR
OCT imaging, however, requires longer acquisition
times, and two-dimensional images consisting of
3000 axial and 600 transverse pixels would take
several seconds to obtain.4
In spectral domain optical coherence tomogra-
phy (SDOCT) technology, the light from the
reference arm interferes with the light reflected
back from the different layers of the retina,
generating spectral interference fringes. This fringe
pattern is processed by a high-speed spectrometer,
and then undergoes Fourier transformation to
create a reflectivity profile in depth. Therefore,
SDOCT has also been called Fourier domain OCT
(FDOCT).5 The three-dimensional structure of the
retina can therefore be reconstructed by laterally
scanning the laser beam across the retina. Instead
of acquiring depth information by looking at the
change in interference pattern in time, as in
TDOCT, the SDOCT system acquires depth
information by analysing the interference pattern
in the spectrum of mixed reflected lights.
SDOCT’s fundamentally different detection
method which utilises a spectrometer is more
efficient and therefore allows for a 150-fold
improvement in sensitivity compared with equiva-
lent TDOCT systems.6–9 This higher sensitivity
allows for faster acquisition speeds and for detec-
tion of weaker signals.10 Therefore, axial resolu-
tions of about 2 mm are possible with SDOCT.11
Ultrahigh speeds of 34.1 ms per A-line can be
obtained. Single images comprising 1000 A-lines
can be acquired in 34.1 ms or 1/29 of a second.
These faster acquisition speeds allow SDOCT to
scan larger areas of the retina.
Our study seeks to demonstrate how SDOCT
may improve the clinical care of AMD patients, in
that our new algorithm can determine drusen area
and volume automatically. Past studies have
shown that drusen diameter and area may be
significantly associated with risk of progression to
advanced AMD over 5 years; however, the detailed
analysis of drusen diameter and area made it
cumbersome to use clinically.16–18 With this new
algorithm, SDOCT technology could potentially
provide more objective and easier classification of
AMD according to drusen size or area, which will
help determine the disease prognosis for certain
patients.
In this paper, we demonstrate SDOCT images of
three eyes of three patients with non-neovascular
AMD. We demonstrate a new automated algo-
rithm which calculates drusen area and volume.
METHODS
Study protocols were approved by the
Massachusetts Eye and Ear Infirmary and
Massachusetts General Hospital Institutional
Review Boards and in accordance with the
Health Insurance Portability and Accountability
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Act. Patients were enrolled after informed consent was
obtained.
An experimental SDOCT instrument was developed at the
Massachusetts General Hospital, Wellman Center for
Photomedicine. The descriptions of the setup and the basic
theory have been published in detail.9 10 12 For the light source,
both a superluminescent diode (SLD, Superlum, Russia) with a
full width at half maximum (FWHM) spectral width of 50 nm
centred at 840 nm and a Ti:Sapphire laser with a FWHM
spectral width of 140 nm centred at 800 nm were used. The
Figure 1 Colour fundus photograph and
StratusOCT fast macular scan of the right
eye of a patient with dry age-related
macular degeneration (patient A). (A)
Multiple large soft drusen temporal to the
macula. (B) Six standard OCT radial scans
showing only two frames show small
drusen (arrowhead). (C) Radial lines
indicating the positions and directions of
the six radial scans.
Figure 2 Spectral domain optical coherence tomography (SDOCT) images of the right eye of a patient with dry age-related macular degeneration
(patient A). (A) Integrated reflectance image. Letters a, b and c indicate the position of the selected frames. (B) Upper frame: centre of the fovea (a,
asterisk, top right); middle frame: from inferior to the fovea (b, middle right). Last frame (c, bottom right): several drusen temporal to macula (hollow
arrows). Note the reduced reflectance of the boundary between the inner and outer segments of the photoreceptors (IS/OS) around drusen (short
arrows). (C) Baseline (blue line) and drusen boundary (lower red line) as determined by our algorithm. The single frames are expanded vertically by 2.67
for better visualisation of the retinal layers. The light source was a Ti:sapphire laser with axial resolution of 3 mm. G/IPL, ganglion cell/inner plexiform
layer; INL, inner nuclear layer; IS/OS, boundary between the inner and outer segments of the photoreceptors; ONL, outer nuclear layer; OPL, outer
plexiform layer; RNFL, retinal nerve fibre layer; RPE, retinal pigment epithelium.
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incident optical power in the eye was about 600 mW in both
cases, well below the American National Standards Institute
(ANSI) standards.13 A retinal tracker as described in previous
publications was utilised.14 15 The purpose of the lateral retinal
tracker was to compensate for involuntary eye motions during
the scan that would manifest as image discontinuities and
jumps that are typically seen in StratusOCT images.
The axial distance was calibrated by measuring a mirror in a
model eye with 100 mm incremental steps by translating a
mirror in the reference arm, giving peaks in the depth profiles at
100 mm intervals. The resulting measured distance was divided
by 1.38 to correct for the average refractive index of the retinal
tissue.9 The lateral distance was calibrated by measuring the
angular sweep entering the eye. The angle was converted to a
distance assuming a fixed eye length of 23 mm and a vitreal
refractive index of 1.34, giving a conversion factor of ,300 mm/
u. Refractive error does not affect the lateral distance calibration,
but an eye length that deviates from an average of 23 mm may.
We assume an average eye length of 23 mm, since we excluded
high myopes from our study, and we only included patients
with refractive errors of 25 dioptres to +5 dioptres.
Images from patients A and B are shown to compare
information received from StratusOCT versus SDOCT imaging
(fig 1). Images from patients B and C are shown to demonstrate
pigmentary clumping, atrophy and drusen in non-neovascular
AMD.
A quantitative analysis of SDOCT images from patient A was
performed (figs 2, 3). The automatic algorithm6 searched along
each depth profile (A-line) for the lowest boundary in the OCT
image which corresponded to the posterior retinal pigment
epithelium (RPE) border. In areas where drusen were detected,
the identified RPE boundary was determined to be the anterior
boundary of the drusen. To determine the posterior border of
the drusen (blue line, fig 2C), the original RPE boundary was
then fitted with a second-order polynomial to determine the
original RPE position (baseline) before the drusen accumulation
occurred. The difference between the identified posterior RPE
border and calculated baseline provided the geometric dimen-
sions of the drusen (lower red line, fig 2C). The dimensions of
drusen were determined based on the fundus photographs, too.
Time domain optical coherence tomography images were
obtained using the StratusOCT (Carl Zeiss Meditec). The fast
macular thickness map protocol was used.
Patients were recruited from the Massachusetts Eye and Ear
Infirmary and were as follows:
c Patient A: The right eye of a 54-year-old black female was
imaged with both StratusOCT and SDOCT. She was noted
to have multiple large drusen on a routine eye examination
and was diagnosed as having non-neovascular AMD. Her
corrected visual acuity was 20/20 OD with 23.00
20.25675u.
c Patient B: The right eye of an 82-year-old Caucasian male
was imaged with both StratusOCT and SDOCT. He had
initially been diagnosed as having non-neovascular AMD
14 years ago. There were multiple large drusen in his retina.
His best corrected visual acuity was 20/60 OD with +0.50
22.506105u.
c Patient C: The right eye of a 58-year-old Caucasian male
was imaged with SDOCT. He had several retinal pigmen-
tary clumps in his macula and was diagnosed as having non-
neovascular AMD. The visual acuity of that eye was 20/25
with +1.50 20.25670u.
Prior to imaging, eyes were dilated with 5% phenylephrine
hydrochloride and 0.8% tropicamide.
RESULTS
The right eye of patient A showed multiple soft drusen
temporal to the macula (fig 1A). A StratusOCT macular scan
only showed drusen in two of the six radial scans (fig 1B,C,
white arrowheads). Drusen or retinal pigment epithelium (RPE)
elevations could not be found easily on the other radial scans
(a, c, d, f). Patient A was also imaged with SDOCT (fig 2).
These pictures were select frames from a 4.97 mm
65.18 mm61.24 mm volume scan, which consisted of 200
frames acquired at 29 frames per second. The original frames
were made of 1000 A-lines, but they were cropped to 960 A-lines
per frame to remove side artefacts due to fast scanning. On
these SDOCT images, multiple elevations consistent with
drusen are clearly shown (hollow arrows).
The black and white fundus images shown in the left panel of
fig 2, right panel of fig 4 and left panel of fig 5 were obtained
from the three-dimensional SDOCT scans by simply integrating
each reflectivity depth profile (or A-line). These images, called
integrated reflectance images, are very similar to scanning laser
ophthalmoscope (SLO) images.6 Although both SLO and OCT
use scanning laser beams, a typical SLO uses a single detector
that collects the light reflected from all the retinal layers
measuring an overall reflectance. By integrating the reflectivity
profile in OCT, we can obtain the same overall reflectance. The
additional depth discrimination of OCT distinguishes these two
technologies; however, for the purpose of illustrating the en face
retinal map, the two technologies can display similar images.
These SDOCT integrated reflectance images can generate
fundus images with a similar resolution and quality to that of
SLO. The horizontal lines across these SDOCT integrated
reflectance images indicate the position of the two-dimensional
scans shown either below or to the right side of these figures.
For patient A, the posterior border of the RPE was analysed
three-dimensionally (figs 2, 3). For a quantitative analysis of
drusen, the identified RPE boundary from the automated
algorithm6 was fitted with the calculated original RPE position
(baseline; fig 2C). The difference between these two curves
delimited the final drusen dimensions.
Figure 3 shows the result of the drusen analysis algorithm,
which calculates the drusen area (fig 3B,C), shape (fig 3D), and
volume (fig 3E). The colour bars are scaled in micrometres and
denote the height of the drusen. For example, the calculated
base area of a single druse (fig 3E) is 0.146 mm2, and the volume
of this drusen is 9.3161023 mm3.
The dimension of the drusen can be mapped with false-colour
coding (fig 3B). A two-dimensional binary map of drusen within
the retinal SDOCT scan area (fig 3C) shows the drusen shape at
the baseline, as obtained from an analysis of the SDOCT data.
Drusen which are elevated above the baseline more than 8 mm
(5 pixels of 1.6 mm) are shown as white, and the proportion of
retina with drusen was calculated as 5.85% of the total scan
surface.
Patient B (fig 4) had multiple large drusen. StratusOCT scans
show multiple drusen (fig 4C, arrowheads). The RPE irregular-
ity is partly caused by motion artefact and may make it difficult
to distinguish a small druse from motion artefacts. The SDOCT
scan shows the striking features of multiple discrete round RPE
elevations (fig 4D, arrowheads). Geographic atrophy (maximum
linear dimension of 567 mm) is noted nasal to the fovea on the
fundus photo (fig 4A, short arrow), which corresponds to the
Straus OCT images (fig 4C, short arrows) and SDOCT images
(fig 4D, short arrows), both of which show increased transmis-
sion due to pigment loss. This geographic atrophy fits into the
category of central geographic atrophy, with a grade 3 size for
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the Age-related Eye Disease Study (AREDS) grading scale.16 The
scanned volume is 5.0 mm65.18 mm61.56 mm. One hundred
frames were acquired at 29 frames per second, with 963 A-lines
displayed for each frame. The RPE is straighter and with less
motion artefact compared with the StratusOCT images.
Patient C had several areas of pigment clumping with
surrounding atrophy in the superior macula (fig 5A, arrows).
One of these pigment clumps was sized as 223 mm, which fitted
into grade 4 of the AREDS grading scales (ie, increased pigment
size equal to or above 125 mm but less than 250 mm).16 From his
SDOCT scans, four frames are shown (fig 5B). Frames a and b are
SDOCT images from a 6.35 mm66.9 mm61.67 mm scanned
volume. Frames c and d are SDOCT images from a
3.81 mm66.9 mm61.67 mm scanned volume. Both settings have
460 A-lines for one frame, with 150 frames acquired at 29 frames
per second. Frames from both of the settings scanned a similar
area of retina (shown as the white and black horizontal lines on
the integrated reflectance image). For better delineation of
structures, frames are expanded vertically by 2.7 times for frames
a and b but by only 1.5 times for frames c and d. Small hyper-
reflective elevations (hollow arrows) just above the level of the
RPE correspond to the pigment clumping noted in fig 5 and imply
RPE hyperplasia. The overlying retinal layers look well preserved.
DISCUSSION
OCT is a valuable imaging tool for the evaluation of retinal
diseases, because it is non-invasive and relatively affordable.
Most importantly, OCT provides ophthalmologists with
clinically relevant images that correlate well with histol-
ogy.10 19 20 Numerous advances in the diagnosis of retinal
diseases as well as improved understanding of retinal pathology
can be obtained with OCT technology, and OCT is now also
used to guide therapy.21
The leading commercially available OCT instrument
(StratusOCT) as well as the experimental UHR systems have
utilised time domain technology. SDOCT can now allow for
unprecedented simultaneous ultra-high speed ultra-high resolu-
tion ophthalmic imaging.9 10 SDOCT can allow for scanning of
the entire posterior pole of the retina, instead of just scanning
the macula with six radial scans and using interpolation to
account for missing data between the radial scans as is currently
used for the fast macular scan in the StratusOCT instrument.
StratusOCT detected only two drusen (fig 1) compared with
the numerous drusen actually seen on fundus photography and
SDOCT scanning (figs 2, 3).
SDOCT images also have fewer motion artefacts than
StratusOCT. In fig 4, some areas of RPE between the drusen
Figure 3 Results of the automated drusen analysis from fig 2. (A) Retinal area of drusen analysis. (B) Corresponding retina with a false-colour scale
after analysis. (C) Retina area with drusen, elevated above the baseline more than 8 mm (5 pixels of 1.6 mm), shown as white. The proportion of retina
with drusen was calculated as 5.85% of the total scan surface. (D) Analysed retina displayed three-dimensionally. The height was elongated in this
figure by five times. The colour bars are scaled as actual size in microns. (E) One of the drusen (circled, from top figures) shown without height
elongation. The calculated area of this druse is 1.466105 mm2 or 0.146 mm2, and the volume is 9.316106 mm3 or 9.3161023 mm3. The total area of
scan was 4.97 mm65.18 mm61.24 mm.
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show undulation due to motion artefact in the StratusOCT
image. In the SDOCT image for the same patient (fig 4D), the
flatter RPE and retinal layers are relatively free from motion
artefact, and the margins of the drusen are clearer. This shows
how SDOCT can improve the ease with which we can interpret
OCT images.
Because of its faster acquisition speeds, SDOCT can provide
much more information compared with the standard TDOCT
(fig 3). For example, SDOCT can create three-dimensional scans
of large areas (ie, up to a 30u field of view) in under 10 s and can
also display three-dimensional tomographic videos of the optic
nerve head and retina. In contrast, the slow acquisition speed of
TDOCT can only practically scan two-dimensional images and
does not have video capabilities. SDOCT’s more comprehensive
visualisation of retinal structures could potentially improve the
evaluation and treatment of AMD. Because SDOCT also allows
for higher-resolution imaging, this imaging technology may
further decrease the need for repeated fluorescein angiography.
By the end of 2006, some companies obtained FDA approval
to market SDOCT machines. Some of these companies include
Heidelberg Engineering (Spectralis, Germany), Carl Zeiss
Meditec (Cirrus, Dublin, California), Optopol Technology Sp.
z.o.o. (SOCT Copernicus, Zawiercie, Poland), and Optovue Co.
(RTVue-100, Fremont, California).
Interestingly, there is reduced reflectance of the boundary
between the inner and outer segments of the photoreceptors
(IS/OS) around drusen (fig 2, short arrows). This reduced
reflectance is not seen with the lower-resolution StratusOCT
images (figs 1, 4). Even with cases of non-neovascular AMD, the
photoreceptor layer, especially rods, can be damaged because of
the dysfunctional RPE.22 This may be associated with structural
changes in the photoreceptor layer and the IS/OS that may
result in reduced reflectivity of the IS/OS, especially in areas
overlying drusen. The elevation of RPE over the dome-shaped
drusen may also change the reflectance of the IS/OS by
disrupting the original orderly vertical arrangement of photo-
receptors. These are both possible explanations for the decreased
reflectance of the IS/OS.
New automated algorithms that determine the total volume
or area of all scanned drusen as well as the proportion of retinal
area with drusen could potentially provide meaningful para-
meters for evaluating AMD disease level and progression (fig 3).
Drusen area as well as drusen size has been proven as an
important indicator of AMD progression.16–18 On a recent report
describing a simplified severity scale, AREDS implied that
drusen size was used instead of drusen area, because assessment
of drusen area was more difficult.17 SDOCT may solve the
problem of drusen assessment (fig 3). These algorithms may
also facilitate treatment decisions. For example, according to the
AREDS, drusen size may be a parameter used to decide whether
a patient would benefit from AREDS vitamin supplements.23 An
automated algorithm that determines drusen area objectively
Figure 4 Colour fundus photograph and optical coherence tomography (OCT) imaging of the right eye of a patient with dry age-related macular
degeneration (patient B). (A) Small degree of geographic atrophy noted nasal to the fovea (short arrow). (B) Integrated reflectance image. Letters a and
b indicate the position of the selected frames. (C) Horizontal scan from the StratusOCT showing multiple drusen (arrowheads). (D) Spectral domain OCT
images. Increased transmission due to pigment loss (short arrows) is noted along with the drusen (arrowheads). The light source was a Ti:sapphire
laser with an axial resolution of 3 mm. G/IPL, ganglion cell/inner plexiform layer; INL, inner nuclear layer; IS/OS, boundary between the inner and outer
segments of the photoreceptors; ONL, outer nuclear layer; OPL, outer plexiform layer; RNFL, retinal nerve fibre layer; RPE, retinal pigment epithelium.
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would potentially make the decision whether to use AREDS
vitamin supplements quicker for the treating physician.
Reproducibility and validation studies of this algorithm are still
needed.
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Figure 5 Colour fundus photograph and spectral domain optical coherence (SDOCT) images of the right eye of a patient with dry age-related macular
degeneration (patient C). (A) Several pigment clumpings with surrounding atrophy (arrows) in the superior macula in fundus photography. (B) Small
hyper-reflective elevations (hollow arrows) just above the level of the retinal pigment epithelium (RPE) corresponding to the pigment clumping noted on
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light source was a superluminescent diode laser with an axial resolution of 6 mm. A retinal tracker was applied. G/IPL, ganglion cell/inner plexiform
layer, between the inner and outer segments of the photoreceptors; RNFL, retinal nerve fibre layer; RPE, retinal pigment epithelium. (C) Integrated
reflectance image. The letters a, b, c and d indicate the position and width of the selected frames.
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